Who
David F. Hoffmeister
Director
Company insider
Files Form 4 as: Director, StepStone Group; Director, Glaukos; Director, ICU Medical; Director, Celanese; Chief Financial Officer, Life Technologies.
In numbers
- Trades disclosed
- 229
- Buys
- 1
- Sells
- 3
- Bought
- $997K
- Sold
- $12.3M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 12 May 2006
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | STEP StepStone GroupCapital Markets & Asset Management | SEC FORM 4 Code A | $285K5,616 at $50.74 | filing |
| 8 Sep 2026filed 10 Sep 2026 | STEP StepStone GroupCapital Markets & Asset Management | SEC FORM 4 Code A | $285K5,616 at $50.74 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 23 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,987 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —1,878 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
| 26 May 2026filed 28 May 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
| 26 May 2026filed 28 May 2026 | GKOS Glaukosoption or derivative · Medical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
| 26 May 2026filed 28 May 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code M | $370K15,000 at $24.69 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU MedicalMedical Devices | SEC FORM 4 Code M | —1,254 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —1,254 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —1,475 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —1,254 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —1,475 at $0.00 | filing |
| 13 May 2026filed 13 May 2026 | ICUI ICU MedicalMedical Devices | SEC FORM 4 Code M | —1,254 at $0.00 | filing |
| 2 Jan 2026filed 7 Jan 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —753 at $0.00 | filing |
| 2 Jan 2026filed 7 Jan 2026 | GKOS GlaukosMedical Devices | SEC FORM 4 Code A | —753 at $0.00 | filing |
News
Celanese Corporation (NYSE:CE) Announces Quarterly Dividend of $0.03CE · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name David F. Hoffmeister; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.